- 138112-78-4Propanamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-2-methyl-
- 138112-82-0Butanamide,4-chloro-N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- 138112-91-1Benzamide,3,5-dichloro-N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- 138112-92-24-Pyridinecarboxamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- 138112-94-42-Quinoxalinecarboxamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- 138112-96-6Urea,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-N'-(phenylmethyl)-
- 138112-99-9Butanamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- 138113-01-61H-Imidazole-4-carboxamide,2,5-dihydro-N-[2-(7-methoxy-1-naphthalenyl)ethyl]-2-oxo-
- 138113-09-41-Naphthaleneethanamine, 7-methoxy-
- 138116-34-43-Pyridinemethanol,4-amino-
Hot Products
- 654671-77-9Sitagliptin phosphate monohydrate
- 274901-16-52-Pyrrolidinecarbonitrile,1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
- 102767-28-2Levetiracetam
- 137234-62-9Voriconazole
- 73-22-3L-Tryptophan
- 202138-50-9Tenofovir disoproxil fumarate
- 8013-07-8Soybean oil, epoxidized
- 360-70-3Nandrolone decanoate
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Agomelatine |
EINECS | 629-727-7 |
| CAS No. | 138112-76-2 | Density | 1.109 g/cm3 |
| PSA | 38.33000 | LogP | 2.91790 |
| Solubility | N/A | Melting Point |
107-109 °C |
| Formula | C15H17NO2 | Boiling Point | 478.8 °C at 760 mmHg |
| Molecular Weight | 243.305 | Flash Point | 243.4 °C |
| Transport Information | N/A | Appearance | white solid |
| Safety | 61 | Risk Codes | 50 |
| Molecular Structure |
|
Hazard Symbols | N |
| Synonyms |
Thymanax;N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide;S 20098;Valdoxan;Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-; |
Article Data | 50 |
Agomelatine Synthetic route
- 139525-77-2
2-(7-methoxynaphthalen-1-yl)ethanamine hydrochloride
- 108-24-7
acetic anhydride
- 138112-76-2
agomelatine
| Conditions | Yield |
|---|---|
| With sodium acetate In ethanol for 1h; Reflux; | 99.5% |
| With sodium acetate In Isopropyl acetate | 99% |
| With sodium acetate In ethanol for 1h; Reflux; | 95% |
- 1331869-01-2
2-(2-methoxynaphthalen-8-yl)acetaldehyde oxime
- 138112-76-2
agomelatine
| Conditions | Yield |
|---|---|
| With hydrogen; acetic anhydride In tetrahydrofuran at 50℃; under 7500.75 Torr; for 6h; Autoclave; Inert atmosphere; | 98% |
| Conditions | Yield |
|---|---|
| Stage #1: N,N-dibenzyl-2-(7-methoxynaphthalen-1-yl)ethanamine With 20% palladium hydroxide-activated charcoal; hydrogen In ethanol; water; ethyl acetate under 3750.38 Torr; for 30h; Autoclave; Stage #2: acetic anhydride With sodium acetate for 4h; | 98% |
| Conditions | Yield |
|---|---|
| In tetrahydrofuran at 0 - 20℃; for 6h; Concentration; Temperature; | 97.5% |
| With sodium acetate In ethanol at 65℃; Green chemistry; | 92% |
| With triethylamine In toluene at 20 - 30℃; | 90% |
| Conditions | Yield |
|---|---|
| With triethylamine In dichloromethane at 0 - 5℃; | 95% |
| In pyridine | 92% |
| With pyridine for 0.5h; Product distribution / selectivity; Cooling with ice; | 92% |
| Conditions | Yield |
|---|---|
| With potassium carbonate In acetone for 5h; Reflux; | 94.5% |
| Conditions | Yield |
|---|---|
| With 5%-palladium/activated carbon; hydrogen In water; ethyl acetate at 20℃; | 92% |
- 1384536-35-9
1-[2-(7-methoxynahthalen-1-yl)-ethyl]-2λ5-triaz-1-en-2-yne
- 108-24-7
acetic anhydride
- 138112-76-2
agomelatine
| Conditions | Yield |
|---|---|
| With palladium 10% on activated carbon; hydrogen In water; ethyl acetate at 20℃; | 92% |
- 1352139-51-5
N-[2-(7-methoxy-3,4-dihydro-naphthalen-1-yl)ethyl]acetamide
- 138112-76-2
agomelatine
| Conditions | Yield |
|---|---|
| With 2,3-dicyano-5,6-dichloro-p-benzoquinone In dichloromethane at 20℃; | 91.8% |
| With 2,3-dicyano-5,6-dichloro-p-benzoquinone for 4h; Product distribution / selectivity; Reflux; | 90% |
| With 2,3-dicyano-5,6-dichloro-p-benzoquinone In tetrahydrofuran at 20℃; Product distribution / selectivity; | 80% |
- 139525-77-2
2-(7-methoxynaphthalen-1-yl)ethanamine hydrochloride
- 75-36-5
acetyl chloride
- 138112-76-2
agomelatine
| Conditions | Yield |
|---|---|
| With potassium carbonate In dichloromethane; water at 0 - 20℃; for 2h; | 91% |
| Stage #1: 2-(7-methoxynaphthalen-1-yl)ethanamine hydrochloride With triethylamine In dichloromethane at 25 - 35℃; for 0.5h; Stage #2: acetyl chloride In dichloromethane at 10 - 20℃; for 1h; | 90% |
| With potassium carbonate In chloroform; water for 0.5h; Ambient temperature; | 89% |
| With potassium carbonate In chloroform; water at 0℃; | |
| Stage #1: 2-(7-methoxynaphthalen-1-yl)ethanamine hydrochloride With potassium carbonate In water; ethyl acetate at 20℃; Schotten-Baumann reaction; Stage #2: acetyl chloride In water; ethyl acetate at 0 - 20℃; for 1h; Schotten-Baumann reaction; |
Agomelatine Specification
1. Introduction of Agomelatine
Agomelatine is one kind of off-white or white crystalline powder or white solid. The IUPAC Name of this chemical is N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide. This chemical belongs to Aromatics Compounds;Aromatics;Neurochemicals;APIS. It should be store at -20°C Freezer. Agomelatine Solubility: Soluble in Chloroform and Methanol. DMSO ≥49mg/mL Water <1mg/mL Ethanol ≥49mg/mL.
Its Classification Code is Central Nervous System Agents; Central Nervous System; Depressants; Drug / Therapeutic Agent; Hypnotics and sedatives.
2. Properties of Agomelatine
Physical properties about Agomelatine are:
(1)Melting Point: 107-109°C; (2)Boiling point: 478.8 °C at 760 mmHg; (3)Flash Point: 243.4 °C ; (4)Density: 1.109 g/cm3; (5)Surface Tension: 41.5 dyne/cm ; (6)Enthalpy of Vaporization: 74.3 kJ/mol ; (7)Vapour Pressure: 2.49E-09 mmHg at 25°C; (8)XLogP3-AA: 2.7; (9)H-Bond Donor: 1; (10)H-Bond Acceptor: 2.
3. Structure Descriptors of Agomelatine
(1)Canonical SMILES: CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC;
(2)InChI: InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17) ;
(3)InChIKey: YJYPHIXNFHFHND-UHFFFAOYSA-N.
4. Toxicity of Agomelatine
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | oral | > 1gm/kg (1000mg/kg) | United States Patent Document. Vol. #5318994, |
5. Uses of Agomelatine
As a Pharmaceutical Intermediates, Agomelatine is used in the treatment of major depressive disorder, emotional disorder. Agomelatine is used in the treatment of major depressive disorder, emotional disorder. The drug substance for Nervous system. Antidepressant, anxiolytic, adjusting the rhythm of sleep and regulating biological clock. Agomelatine is a melatoninergic agonist and selective antagonist of 5-ht2c receptors. Agomelatine is an antidepressant drug. It is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant.
What can I do for you?
Get Best Price
